Skip to main content

and
  1. No Access

    Article

    Efficacy and Safety of Bufei Jiedu Granules in Treating Multidrug-Resistant Pulmonary Tuberculosis: A Multi-center, Double-Blinded and Randomized Controlled Trial

    To assess the efficacy and safety of Bufei Jiedu (BFJD) ranules as adjuvant therapy for patients with multidrug-resistant pulmonary tuberculosis (MDR-PTB).

    Shao-yan Zhang, Lei Qiu, Shun-xian Zhang in Chinese Journal of Integrative Medicine (2024)

  2. Article

    Open Access

    Impact factors of Blastocystis hominis infection in persons living with human immunodeficiency virus: a large-scale, multi-center observational study from China

    Blastocystis hominis (Bh) is zoonotic parasitic pathogen with a high prevalent globally, causing opportunistic infections and diarrhea disease. Human immunodeficiency virus (HIV) infection disrupts the immune sys...

    Shun-**an Zhang, Ji-Chun Wang, Zhong-Wei Li in Infectious Diseases of Poverty (2023)

  3. Article

    Open Access

    The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. Hence, control measures are continuously being optimized to guard ...

    **-**n Zheng, Shan Lv, Li-Guang Tian, Zhao-Yu Guo in Infectious Diseases of Poverty (2022)

  4. Article

    Open Access

    Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial

    Influenza can fall into three categories according to severity: mild influenza, severe influenza, and critical influenza. Severe influenza can result in critical illness and sometimes death particularly in pat...

    Lei Qiu, **an-wei Wu, Shao-yan Zhang, Ming Yang, Shun-xian Zhang, Ji-you Fu in Trials (2021)

  5. Article

    Open Access

    Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial

    The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a significant number of mortalities worldwide. COVID-19 poses a serious threat to human...

    Zhen-Hui Lu, Chun-Li Yang, Gai-Ge Yang, Wen-Xu Pan in Infectious Diseases of Poverty (2021)

  6. Article

    Open Access

    Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen

    China is the second highest pulmonary tuberculosis (PTB) burden country worldwide. However, retreatment of PTB has often developed resistance to at least one of the four first-line anti-TB drugs. The cure rate...

    Shao-Yan Zhang, Ji-You Fu, **ao-Yan Guo, Ding-Zhong Wu in Infectious Diseases of Poverty (2020)

  7. Article

    Erratum to: Synergistic protective effect of picroside 11 and NGF on P12 cells against oxidative stress induced by H2O2

    Jian-wen Liu, You-jun Yu, Pei-yong Zheng, **ao-dong Zhang in Pharmacological Reports (2009)